Amgen Must Face Regeneron's Bundling Antitrust Suit
Amgen can't escape a lawsuit accusing it of using a bundling scheme to increase the sales of its cholesterol drug Repatha and push competitors out of the market, a Delaware federal...To view the full article, register now.
Already a subscriber? Click here to view full article